ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Internal Medicine

Top Internal Medicine Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RANDALL LEDUC MD

Internal Medicine

16,630

$844K

430
368 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $61

G. CORNETT M.D.

Internal Medicine

16,459

$910K

599
509 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $61

S MARRI M.D.

Internal Medicine

16,346

$923K

495
382 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

21%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $61

ANDREW HART MD

Internal Medicine

16,078

$693K

655
549 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$43
Average prescription price

Avg: $61

JAMES HAMBIDGE MD

Internal Medicine

15,819

$813K

667
624 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $61

WAEL BAKDASH M.D.

Internal Medicine

15,804

$936K

460
282 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

27%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $61

MICHAEL YOUNG MD

Internal Medicine

15,795

$961K

589
496 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $61

PRATAP SINGH MD

Internal Medicine

15,765

$619K

394
342 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

31%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$39
Average prescription price

Avg: $61

MILTON GASPARIS MD PHD

Internal Medicine

15,753

$1.09M

789
680 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

29%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$69
Average prescription price

Avg: $61

RUPINDER GILL MD

Internal Medicine

15,692

$906K

348
245 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

31%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $61

SCOTT MIETHKE MD

Internal Medicine

15,679

$791K

601
494 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $61

SANJAY PATEL M.D.

Internal Medicine

15,651

$1.13M

587
460 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$72
Average prescription price

Avg: $61

THOMAS DEVINE MD

Internal Medicine

15,502

$865K

487
448 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $61

ROBERT HOLMES MD

Internal Medicine

15,389

$856K

526
449 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $61

WILLIAM BUCKLEY M.D.

Internal Medicine

15,336

$1.13M

755
663 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$74
Average prescription price

Avg: $61

JOHN MATHEW MD

Internal Medicine

15,325

$888K

591
481 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $61

NANCY MILES MD

Internal Medicine

15,247

$818K

589
356 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $61

RICHARD SPALDING M.D.

Internal Medicine

15,166

$896K

649
501 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

30%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $61

ALAN STEWART M.D.

Internal Medicine

14,980

$674K

406
356 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

37%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $61

MARK DAVISSON M.D.

Internal Medicine

14,895

$853K

616
469 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

23%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $61

DAVID MORRICAL M.D.

Internal Medicine

14,874

$777K

505
467 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $61

THOM BUNNELL DO

Internal Medicine

14,643

$828K

563
443 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $61

TIMOTHY FISHER MD

Internal Medicine

14,588

$693K

714
626 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $61

TECHSIN TY MD

Internal Medicine

14,563

$825K

459
300 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

28%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $61

KURT SCHLECK MD

Internal Medicine

14,545

$645K

690
634 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank